Approvals/TGA/FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension

Approved

STANDARD

FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension

Eisai Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ec2b5fcdbfd326ea
Product Name: FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension
Artg Id: 332505
Artg Name: FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension
Sponsor: Eisai Australia Pty Ltd
Company Detail Path: /organization/eisai-australia-pty-ltd
Artg Date: 2021-02-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-CMI-02671-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-02011-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ec2b5fcdbfd326ea

Type

Standard